Opus Genetics Inc
NASDAQ:IRD

Watchlist Manager
Opus Genetics Inc Logo
Opus Genetics Inc
NASDAQ:IRD
Watchlist
Price: 1.92 USD -2.54% Market Closed
Market Cap: 114.5m USD

Intrinsic Value

The intrinsic value of one IRD stock under the Base Case scenario is 0.62 USD. Compared to the current market price of 1.92 USD, Opus Genetics Inc is Overvalued by 68%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IRD Intrinsic Value
0.62 USD
Overvaluation 68%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Opus Genetics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about IRD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is IRD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Opus Genetics Inc.

Explain Valuation
Compare IRD to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IRD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Opus Genetics Inc

Current Assets 38.4m
Cash & Short-Term Investments 32.4m
Receivables 4.6m
Other Current Assets 1.4m
Non-Current Assets 226k
PP&E 226k
Efficiency

Free Cash Flow Analysis
Opus Genetics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Opus Genetics Inc

Revenue
15.4m USD
Operating Expenses
-49.9m USD
Operating Income
-34.5m USD
Other Expenses
-23.8m USD
Net Income
-58.3m USD
Fundamental Scores

IRD Profitability Score
Profitability Due Diligence

Opus Genetics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Low 3Y Average Gross Margin
Low Gross Margin
Negative 3Y Average Net Margin
29/100
Profitability
Score

Opus Genetics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

IRD Solvency Score
Solvency Due Diligence

Opus Genetics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
57/100
Solvency
Score

Opus Genetics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IRD Price Targets Summary
Opus Genetics Inc

Wall Street analysts forecast IRD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IRD is 6.94 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.

Lowest
Price Target
5.05 USD
163% Upside
Average
Price Target
6.94 USD
261% Upside
Highest
Price Target
9.45 USD
392% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Opus Genetics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IRD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

IRD Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IRD stock?

The intrinsic value of one IRD stock under the Base Case scenario is 0.62 USD.

Is IRD stock undervalued or overvalued?

Compared to the current market price of 1.92 USD, Opus Genetics Inc is Overvalued by 68%.

Back to Top